ArticleThe Journal of experimental medicine2019

Atherogenic LOX-1 signaling is controlled by SPPL2-mediated intramembrane proteolysis.

Torben Mentrup et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.